ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.

Angie M Torres-Adorno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.